NoDirection.newsWe find the facts. You decide.
How outlets are reporting this

Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback

1 source · first reported 6 h ago · latest 6 h ago
L 0% · C 100% · R 0%1 outlet
Collecting coverage · 1 outlet so far

Only a few outlets are reporting this so far. We write a full story once several independent outlets cover an event. Follow it and it appears on your Following page the moment our story is ready.

Every headline

Compare how each outlet framed the same event. Links open the original article.

Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback | NoDirection News